Neuroendocrine Tumor Imaging Update

Course overview

UAN: 0018-0000-21-216-H01-P & T RELEASE: 07/12/2021 EXPIRE: 07/12/2024 CREDITS: 1.0 LEARNING OBJECTIVES: 1. Identify the characteristics of neuroendocrine tumors (NETs) 2. Compare diagnostic modalities and treatment options 3. Review Copper Cu64 dotatate clinical trials 4. Prepare the pharmacy for Copper Cu64 dotatate injection NOTE: An annual subscription for Purdue's nuclear pharmacy re-certification program provides access to both the continuing education component of the program and the "Radiopharmacy Portal" a reference resource for practitioners. Subscriptions to the continuing educational offerings, which have been accredited through ACPE and BPS, can be purchased for an annual fee of $195 for nuclear pharmacists and $95 for nuclear pharmacy technicians.